BODY AND MIND INC (BMMJ) Financials

BMMJ

Trailing 12 months to April 30, 2024

Revenue $22.7M YoY not available

Net Income -$13.8M YoY not available

Free Cash Flow -$4.3M YoY not available

Operating Cash Flow -$4.2M YoY not available

Market Cap $30K as of Oct 9, 2026

Price / Sales 0.0x on $22.7M revenue, trailing 12 months to April 30, 2024

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to April 30, 2024

Price / Book n/m negative shareholder equity, so no book multiple, Q3 FY2024

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 9, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2024, ended Apr 30, 2024 Reported Jun 20, 2024 Currency USD FYE July

Newest figures come from the 10-Q for Q3 FY2024, filed Jun 20, 2024. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BMMJ SEC filings page.

BODY AND MIND INC (BMMJ) reported $22.7M in revenue over the twelve months to Apr 30, 2024. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BMMJ FY2023 2026-10-03

The business has lost operating leverage: near-flat sales now coincide with negative equity and cash outflows rather than durable profitability.

By FY2023, revenue was $22.8M and operating cash flow was -$3.8M, versus positive operating cash flow in FY2021. The simultaneous narrowing of gross margin to 25.3% and free cash flow of -$4.8M shows weaker sales economics were translating into funding needs, not merely an accounting loss.

Assets fell to $21.2M while liabilities reached $30.5M in FY2023, leaving negative equity and shifting the story from profitability alone to solvency and financing structure. The 1.1x current ratio, alongside a reported 4.6 months of annual outflow comparison, points to little room between near-term resources and obligations.

Gross profit of $5.8M did not cover an operating loss of $7.7M, indicating that costs below direct production expenses remained substantial. FY2022's net loss of $28.2M was far larger than its operating loss of $4.5M, showing that reported earnings were also heavily affected below operating income that year.

Financial Health Signals

Financial health score not available

BODY AND MIND INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-4.49

BODY AND MIND INC scores -4.49, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($30K) relative to total liabilities ($30.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/7

BODY AND MIND INC passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

BODY AND MIND INC reported a net loss of $20.6M while operations used $3.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.4M

YoY+5.6%

QoQ-0.5%

BODY AND MIND INC generated $4.4M in revenue in Q3 2024. This represents an increase of 5.6% from the same quarter a year earlier. Against the prior quarter it is down 0.5%.

EBITDA

-$1.2M

YoY-21.9%

QoQ-66.4%

BODY AND MIND INC's EBITDA was -$1.2M in Q3 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 21.9% from the same quarter a year earlier. Against the prior quarter it is down 66.4%.

Net Income

-$2.5M

YoY+29.7%

QoQ-1403.7%

BODY AND MIND INC reported -$2.5M in net income in Q3 2024. This represents an increase of 29.7% from the same quarter a year earlier. Against the prior quarter it is down 1403.7%.

EPS (Diluted)

Not reported for Q3 2024.

Cash & Balance Sheet

Free Cash Flow

-$1.3M

YoY-93.3%

QoQ-818.2%

BODY AND MIND INC recorded an outflow of $1.3M in free cash flow in Q3 2024, representing a cash shortfall after capex. This represents a decrease of 93.3% from the same quarter a year earlier. Against the prior quarter it is down 818.2%.

Cash & Debt

$292K

YoY-88.3%

QoQ-80.0%

5Y CAGR-35.4%

BODY AND MIND INC held $292K in cash as of Q3 2024; long-term debt is not reported for that period.

Shares Outstanding

148M

YoY+0.7%

QoQ0.0%

BODY AND MIND INC had 148M shares outstanding in Q3 2024. This represents an increase of 0.7% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q3 2024.

Margins & Returns

Gross Margin

44.6%

YoY-1.6pp

QoQ-1.1pp

BODY AND MIND INC's gross margin was 44.6% in Q3 2024, indicating the percentage of revenue retained after direct costs. This is down 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.1 percentage points.

Operating Margin

-30.4%

YoY+0.4pp

QoQ-11.3pp

BODY AND MIND INC's operating margin was -30.4% in Q3 2024, reflecting core business profitability. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 11.3 percentage points.

Net Margin

-57.6%

YoY+28.9pp

QoQ-53.8pp

BODY AND MIND INC's net profit margin was -57.6% in Q3 2024, showing the share of revenue converted to profit. This is up 28.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 53.8 percentage points.

Return on Equity

Not reported for Q3 2024.

Capital Allocation

Capital Expenditures

YoY-100.0%

QoQ-100.0%

BODY AND MIND INC reported no capital expenditure in Q3 2024. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

R&D Spending

Not reported for Q3 2024.

Share Buybacks

Not reported for Q3 2024.

BMMJ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BMMJ quarterly income statement

Metric	TTM	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Revenue	$22.7M	$22.8M-2.4%	$23.4M-13.1%	$26.9M+331.6%	$6.2M+16.8%	$5.3M+98.2%	$2.7M	N/A
Cost of Revenue	$15.4M	$17.0M+7.0%	$15.9M+16.2%	$13.7M+262.8%	$3.8M+33.5%	$2.8M+132.7%	$1.2M	N/A
Gross Profit	$7.2M	$5.8M-22.4%	$7.4M-37.9%	$12.0M+694.9%	$1.5M-15.3%	$1.8M+48.9%	$1.2M	N/A
SG&A Expenses	N/A	$235K+4.9%	$224K-70.8%	$766K-89.1%	$7.1M+52.6%	$4.6M+234.3%	-$3.4M-1077.3%	$352K
Operating Income	-$6.1M	-$7.7M-70.0%	-$4.5M-868.2%	$587K+110.6%	-$5.5M-95.1%	-$2.8M	N/A	N/A
EBITDA	N/A	-$6.6M-90.1%	-$3.4M-268.7%	$2.0M+137.6%	-$5.4M-112.9%	-$2.6M	N/A	N/A
Interest Expense	N/A	N/A	$1.4M+2470.0%	$53K-59.8%	$133K-89.3%	$1.2M+348.3%	$277K	N/A
Income Tax	-$1.8M	-$2.2M-22.2%	-$1.8M-181.9%	$2.2M+1514.9%	$134K	$0+100.0%	-$239K	N/A
Net Income	-$13.8M	-$20.6M+27.1%	-$28.2M-1328.2%	-$2.0M+57.0%	-$4.6M-22.5%	-$3.8M-110.7%	-$1.8M-385.1%	-$367K

Metric	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K
Revenue	$4.4M+5.6%	$4.4M-0.1%	$5.5M-6.7%	$8.4M	$4.2M-47.0%	$4.4M-44.9%	$5.8M-22.7%	N/A
Cost of Revenue	$2.4M+8.8%	$2.4M-9.6%	$3.4M-31.5%	$7.1M	$2.2M-57.8%	$2.7M-47.0%	$5.0M+22.3%	N/A
Gross Profit	$2.0M+2.0%	$2.0M+14.2%	$2.0M+137.4%	$1.2M	$1.9M-24.7%	$1.8M-32.7%	$860K-72.7%	N/A
SG&A Expenses	N/A	N/A	$66K-72.1%	N/A	N/A	N/A	$235K+34.4%	N/A
Operating Income	-$1.3M-4.4%	-$844K+41.1%	-$1.2M+46.0%	-$2.8M	-$1.3M+4.3%	-$1.4M-47.7%	-$2.2M-783.3%	N/A
EBITDA	-$1.2M-21.9%	-$748K+35.7%	-$1.1M+43.1%	-$2.5M	-$1.0M-14.3%	-$1.2M-118.3%	-$1.9M-389.7%	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	$425K+25.0%	$381K+12.6%	N/A
Income Tax	$388K-13.6%	$532K+43.7%	$838K+48.3%	-$3.6M	$449K-45.3%	$370K+126.2%	$565K-19.6%	N/A
Net Income	-$2.5M+29.7%	-$169K+93.8%	$164K+105.5%	-$11.3M	-$3.6M-46.6%	-$2.7M-0.7%	-$3.0M-336.0%	N/A
EPS (Basic)	N/A	N/A	-$0.030.0%	N/A	N/A	N/A	-$0.03	N/A
Diluted Shares (Avg)	N/A	N/A	147M+29.0%	N/A	N/A	N/A	114M+3.6%	N/A

Not reported in any period shown, so not listed: R&D Expenses, EPS (Diluted).

BMMJ Balance Sheet

BMMJ quarterly balance sheet

Metric	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Total Assets	$21.2M-31.6%	$31.0M-35.5%	$48.1M+24.0%	$38.8M+7.1%	$36.2M+133.6%	$15.5M+2906.6%	$516K
Current Assets	$9.4M-27.4%	$13.0M-9.2%	$14.3M+155.4%	$5.6M-51.7%	$11.6M+476.7%	$2.0M+387.3%	$412K
Cash & Equivalents	$1.5M+2.0%	$1.4M-80.6%	$7.4M+445.4%	$1.4M-85.0%	$9.0M+2672.1%	$325K-11.4%	$367K
Short-Term Investments	$0	$0	$0	$0	$0-100.0%	$78K	$0
Inventory	$910K-74.5%	$3.6M+21.4%	$2.9M+65.9%	$1.8M+27.3%	$1.4M+45.8%	$953K	N/A
Accounts Receivable	$27K-93.8%	$439K-71.6%	$1.5M+58.8%	$973K+3.5%	$940K+48.6%	$632K+3453.6%	$18K
Long-Term Investments	$0	$0	$0-100.0%	$8.9M+3381.1%	$256K+229.9%	$78K	$0
Goodwill	N/A	$0-100.0%	$5.2M+96.1%	$2.6M0.0%	$2.6M0.0%	$2.6M	N/A
Total Liabilities	$30.5M+46.0%	$20.9M+51.9%	$13.8M+150.7%	$5.5M+80.6%	$3.0M-35.6%	$4.7M+2342.0%	$193K
Current Liabilities	$8.7M+19.3%	$7.3M+33.3%	$5.5M+95.3%	$2.8M+111.7%	$1.3M-55.9%	$3.0M+1455.0%	$193K
Non-Current Liabilities	$21.8M+60.4%	$13.6M+64.2%	$8.3M+208.6%	$2.7M+56.5%	$1.7M0.0%	$1.7M	$0
Total Equity	-$10.3M-206.7%	$9.6M-71.9%	$34.3M+3.1%	$33.3M+0.3%	$33.2M+207.8%	$10.8M+3245.4%	$322K
Retained Earnings	-$66.8M-45.9%	-$45.8M-167.4%	-$17.1M-15.2%	-$14.9M-41.2%	-$10.5M-55.4%	-$6.8M-35.7%	-$5.0M

Metric	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K
Total Assets	$16.2M-50.4%	$18.0M-44.8%	$17.5M-39.6%	$21.2M-31.6%	$32.6M-38.5%	$32.6M-39.6%	$29.0M-40.8%	$31.0M-35.5%
Current Assets	$4.7M-34.8%	$5.8M-28.4%	$5.7M-15.3%	$9.4M-27.4%	$7.2M-39.3%	$8.1M-35.1%	$6.7M-55.4%	$13.0M-9.2%
Cash & Equivalents	$292K-88.3%	$1.5M-53.5%	$891K-11.5%	$1.5M+2.0%	$2.5M-32.6%	$3.1M-32.2%	$1.0M-86.5%	$1.4M-80.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$633K-76.7%	$644K-77.0%	$2.1M-35.4%	$910K-74.5%	$2.7M-37.2%	$2.8M-31.3%	$3.3M-3.5%	$3.6M+21.4%
Accounts Receivable	$42K-94.6%	$34K-96.0%	$638K+18.4%	$27K-93.8%	$782K-4.4%	$865K-8.0%	$539K-62.7%	$439K-71.6%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%
Total Liabilities	$28.1M-9.4%	$27.8M+0.6%	$27.0M+23.5%	$30.5M+46.0%	$31.0M+36.7%	$27.6M+30.3%	$21.9M+50.1%	$20.9M+51.9%
Current Liabilities	$10.1M-6.0%	$11.8M+38.9%	$9.9M+29.4%	$8.7M+19.3%	$10.8M+13.8%	$8.5M+0.6%	$7.6M+14.7%	$7.3M+33.3%
Non-Current Liabilities	$18.0M-11.2%	$16.0M-16.4%	$17.1M+20.3%	$21.8M+60.4%	$20.3M+53.0%	$19.1M+49.8%	$14.2M+79.7%	$13.6M+64.2%
Total Equity	-$13.1M-1852.8%	-$10.9M-353.0%	-$10.5M-261.0%	-$10.3M-206.7%	$747K-97.5%	$4.3M-86.8%	$6.5M-81.0%	$9.6M-71.9%
Retained Earnings	-$69.6M-25.5%	-$67.0M-29.6%	-$66.7M-36.6%	-$66.8M-45.9%	-$55.5M-137.8%	-$51.7M-148.7%	-$48.9M-172.7%	-$45.8M-167.4%

Not reported in any period shown, so not listed: Long-Term Debt.

BMMJ Cash Flow Statement

BMMJ quarterly cash flow statement

Metric	TTM	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Operating Cash Flow	-$4.2M	-$3.8M-11.3%	-$3.4M-1267.7%	$295K+112.8%	-$2.3M+28.5%	-$3.2M-51.0%	-$2.1M-365.7%	-$459K
Depreciation & Amortization	N/A	$1.1M+4.9%	$1.1M-27.1%	$1.5M+1201.1%	$112K-61.3%	$290K+3186.3%	$9K+454.2%	$2K
Stock-Based Compensation	N/A	$271K-37.8%	$435K-55.4%	$976K-23.7%	$1.3M+45.2%	$881K+11.5%	$790K	N/A
Capital Expenditures	$140K	$993K+275.4%	$265K-34.3%	$402K-53.8%	$872K+136.8%	-$368K-34.8%	-$564K	N/A
Free Cash Flow	-$4.3M	-$4.8M-30.1%	-$3.7M-3350.2%	-$107K+96.6%	-$3.2M+11.6%	-$3.6M-33.1%	-$2.7M	N/A
Investing Cash Flow	$8.7M	-$74K+96.5%	-$2.1M-157.9%	-$832K+84.4%	-$5.3M+37.3%	-$8.5M-216.3%	-$2.7M-2713.2%	-$96K
Financing Cash Flow	-$6.6M	$3.5M+13348.3%	-$27K-100.4%	$6.2M+6687.5%	$91K-99.5%	$20.1M+318.7%	$4.8M+432.3%	$903K

Metric	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K
Operating Cash Flow	-$1.3M-605.9%	$220K+114.0%	-$1.1M-89.9%	-$1.9M	$267K+133.2%	-$1.6M-14281.1%	-$589K-329.6%	N/A
Depreciation & Amortization	$94K-64.0%	$96K-64.4%	$96K-65.8%	$314K	$261K-41.4%	$270K-38.4%	$281K-15.4%	N/A
Stock-Based Compensation	$17K-90.5%	$18K-16.1%	$35K+8.9%	N/A	$178K+94.4%	$22K-85.3%	$32K-77.6%	N/A
Capital Expenditures	$0-100.0%	$32K+580.0%	$80K+1626.8%	$28K	$965K+7208.2%	-$5K-99.2%	$5K-70.3%	N/A
Free Cash Flow	-$1.3M-93.3%	$188K+112.0%	-$1.2M-101.9%	-$2.0M	-$698K+14.5%	-$1.6M-160.6%	-$594K-346.5%	N/A
Investing Cash Flow	$39K+105.1%	$454K+8.4%	$8.0M+7413.5%	$158K	-$758K-1366.6%	$418K+115.2%	$107K+146.1%	N/A
Financing Cash Flow	$7K+120.7%	$7K-99.8%	-$7.2M-89778962.5%	$538K	-$34K-298.0%	$3.0M+20105.1%	-$8+99.6%	N/A

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

BMMJ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BMMJ quarterly financial ratios

Metric	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Gross Margin	25.3%-6.6pp	31.9%-12.7pp	44.6%+20.4pp	24.2%-9.2pp	33.4%-11.0pp	44.4%	N/A
Operating Margin	-33.6%-14.3pp	-19.3%-21.5pp	2.2%+91.2pp	-89.0%-35.7pp	-53.3%	N/A	N/A
Net Margin	-90.1%	-120.8%	-7.3%+66.4pp	-73.8%-3.5pp	-70.3%-4.2pp	-66.1%	N/A
Return on Equity	N/A	-293.1%-287.4pp	-5.8%+8.1pp	-13.8%-2.5pp	-11.3%+5.2pp	-16.5%+97.4pp	-113.9%
Return on Assets	-97.0%-6.0pp	-91.0%-86.9pp	-4.1%+7.7pp	-11.8%-1.5pp	-10.4%+1.1pp	-11.5%+59.7pp	-71.2%
Current Ratio	1.08-0.7x	1.77-0.8x	2.61+0.6x	1.99-6.7x	8.73+8.1x	0.67-1.5x	2.13
Debt-to-Equity	N/A	2.17+1.8x	0.40+0.2x	0.17+0.1x	0.09-0.3x	0.44-0.2x	0.60
Asset Turnover	1.08+0.3x	0.75+0.2x	0.56+0.4x	0.160.0x	0.150.0x	0.17	N/A
FCF Margin	-21.1%-5.3pp	-15.9%-15.5pp	-0.4%+50.6pp	-51.0%+16.4pp	-67.4%	-100.4%	N/A

Metric	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-Q	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K
Gross Margin	44.6%-1.6pp	45.7%+5.7pp	37.4%+22.7pp	14.6%	46.2%+13.7pp	39.9%+7.2pp	14.7%-27.0pp	N/A
Operating Margin	-30.4%+0.4pp	-19.1%+13.3pp	-21.3%+15.5pp	-33.5%	-30.8%-13.7pp	-32.3%-20.3pp	-36.8%-41.0pp	N/A
Net Margin	-57.6%+28.9pp	-3.8%+58.0pp	3.0%+53.5pp	-134.6%	-86.5%-55.3pp	-61.8%-28.0pp	-50.5%-41.5pp	N/A
Return on Equity	N/A	N/A	N/A	N/A	-483.2%-475.0pp	-63.8%-55.4pp	-45.2%-43.2pp	N/A
Return on Assets	-15.7%-4.6pp	-0.9%+7.5pp	0.9%+11.1pp	-53.1%	-11.1%-6.4pp	-8.4%-3.4pp	-10.2%-8.8pp	N/A
Current Ratio	0.46-0.2x	0.49-0.5x	0.57-0.3x	1.08-0.7x	0.67-0.6x	0.96-0.5x	0.88-1.4x	1.77-0.8x
Debt-to-Equity	N/A	N/A	N/A	N/A	41.55+40.8x	6.43+5.8x	3.35+2.9x	2.17+1.8x
Asset Turnover	0.27+0.1x	0.25+0.1x	0.31+0.1x	0.39	0.130.0x	0.140.0x	0.200.0x	N/A
FCF Margin	-30.6%-13.9pp	4.2%+39.6pp	-22.0%-11.8pp	-23.6%	-16.7%-6.4pp	-35.4%-27.9pp	-10.2%-13.3pp	N/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Note: Shareholder equity is negative (-$10.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
BODY AND MIND INC BMMJ	FY2023	$22.8M	-$20.6M	-90.1%	$30K	—
TILT HLDGS INC TLLTF	FY2024	$115.6M	-$99.7M	-86.2%	$44K	—
CTT PHARMACEUTICAL HLDGS CTTH	FY2025	N/A	N/A	N/A	$3.3M	—

Where BODY AND MIND INC Ranks

Frequently Asked Questions

What is BODY AND MIND INC's annual revenue?

BODY AND MIND INC (BMMJ) reported $22.8M in total revenue for fiscal year 2023. This represents a -2.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is BODY AND MIND INC's revenue growing?

BODY AND MIND INC (BMMJ) revenue declined by 2.4% year-over-year, from $23.4M to $22.8M in fiscal year 2023.

Is BODY AND MIND INC profitable?

No, BODY AND MIND INC (BMMJ) reported a net income of -$20.6M in fiscal year 2023, with a net profit margin of -90.1%.

What is BODY AND MIND INC's EBITDA?

BODY AND MIND INC (BMMJ) had EBITDA of -$6.6M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.

What is BODY AND MIND INC's gross margin?

BODY AND MIND INC (BMMJ) had a gross margin of 25.3% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.

What is BODY AND MIND INC's operating margin?

BODY AND MIND INC (BMMJ) had an operating margin of -33.6% in fiscal year 2023, reflecting the profitability of core business operations before interest and taxes.

What is BODY AND MIND INC's net profit margin?

BODY AND MIND INC (BMMJ) had a net profit margin of -90.1% in fiscal year 2023, representing the share of revenue converted into profit after all expenses.

What is BODY AND MIND INC's free cash flow?

BODY AND MIND INC (BMMJ) recorded an outflow of $4.8M in free cash flow during fiscal year 2023. This represents a -30.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is BODY AND MIND INC's operating cash flow?

BODY AND MIND INC (BMMJ) recorded an outflow of $3.8M in operating cash flow during fiscal year 2023, representing cash used by core business activities.

What are BODY AND MIND INC's total assets?

BODY AND MIND INC (BMMJ) had $21.2M in total assets as of fiscal year 2023, including both current and long-term assets.

What are BODY AND MIND INC's capital expenditures?

BODY AND MIND INC (BMMJ) invested $993K in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.

How many shares does BODY AND MIND INC have outstanding?

BODY AND MIND INC (BMMJ) had 147M shares outstanding as of fiscal year 2023.

What is BODY AND MIND INC's current ratio?

BODY AND MIND INC (BMMJ) had a current ratio of 1.08 as of fiscal year 2023, which is considered adequate.

What is BODY AND MIND INC's return on assets (ROA)?

BODY AND MIND INC (BMMJ) had a return on assets of -97.0% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.

What is BODY AND MIND INC's P/E ratio?

BODY AND MIND INC (BMMJ) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to April 30, 2024). The market capitalization is $30K as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is BODY AND MIND INC's price-to-sales ratio?

BODY AND MIND INC (BMMJ) trades at 0.0x sales, its market capitalization divided by revenue of $22.7M revenue, trailing 12 months to April 30, 2024. The market capitalization is $30K as of Oct 9, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does BODY AND MIND INC's liquidity compare with its operating cash outflow?

At the end of fiscal year 2023, BODY AND MIND INC (BMMJ) held $1.5M in cash, cash equivalents and investments, and reported an operating cash outflow of $3.8M over that year. Dividing the one by the other, the reported balance equals about 5 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Why is BODY AND MIND INC's debt-to-equity ratio negative or not reported?

BODY AND MIND INC (BMMJ) has negative shareholder equity of -$10.3M as of fiscal year 2023, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is BODY AND MIND INC's Altman Z-Score?

BODY AND MIND INC (BMMJ) has an Altman Z-Score of -4.49, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is BODY AND MIND INC's Piotroski F-Score?

BODY AND MIND INC (BMMJ) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are BODY AND MIND INC's earnings high quality?

BODY AND MIND INC (BMMJ) reported a net loss of $20.6M while operations used $3.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.